Use of GLP-1 Drugs Under Scrutiny at Winter Olympics

(MedPage Today) — As the Winter Olympic Games get underway, the World Anti-Doping Agency (WADA) is monitoring an unexpected class of drugs: GLP-1 receptor agonists.
An advisory group that makes recommendations about WADA’s list of prohibited…